OpenVSafe by OpenVAERS
Search V-safe

6PA-18526-39402

3 vaccinations 4 coded responses 16 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
0-4
ZIP prefix
551 / MN
Registered
2022-06-24
Relationship
Child or adolescent in my care
Guardian
DT2-13977-62199
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2535359 (opens in a new window) high 11 / 11 — 3 of 5 VAERS symptoms same dose (3) MN matches 2022-09-13 / 2022-12-03 / 2022-12-16
received the same day as the last call
 case 1218780

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2022-06-23
    Dose 1 — Pfizer-BioNTech
  2. 2022-06-24
    Registered in v-safe
  3. 2022-06-25
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-06-26
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-06-28
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-06-30
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-07-09
    Survey response — day 14, dose 1, under 3
    MedDRA: Pyrexia — Feeling: Good · Be unable to work or attend school
    Free text: Fever that lasted for 24+ hours
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-07-14
    Dose 2 — Pfizer-BioNTech
  9. 2022-07-23
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-07-28
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  11. 2022-08-04
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-08-11
    Survey response — day 28, dose 2, under 3
    MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend school
    Free text: Fever, cough, runny nose
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-08-18
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  14. 2022-08-25
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  15. 2022-09-13
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  16. 2022-10-12
    Health check-in — day 28, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  17. 2022-10-20
    Health check-in — day 35, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  18. 2022-10-25
    Health check-in — day 42, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  19. 2022-12-13
    Survey response — 3 months, dose 3, under 3
    MedDRA: Cough, Lacrimation increased, Rhinorrhoea, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Runny nose, water eyes, coughing to the point of vomitting
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-12-13
    Report sent to call center — 3 months, dose 3, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  21. 2022-12-14
  22. 2022-12-16
  23. 2022-12-16
    Call successful
    Completed over the phone
  24. 2023-03-15
    Survey response — 6 months, dose 3, under 3
    MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12022-06-23Pfizer-BioNTech No
22022-07-14Pfizer-BioNTech No
32022-09-13Pfizer-BioNTech Flu

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 12 (Under 3) — day 14, dose 1, under 3

2022-07-09

Symptoms: Fever that lasted for 24+ hours

Release 12 (Under 3) — day 28, dose 2, under 3

2022-08-11

Symptoms: Fever, cough, runny nose

Release 12 (Under 3) — 3 months, dose 3, under 3

2022-12-13

Symptoms: Runny nose, water eyes, coughing to the point of vomitting

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDLacrimation increased · · ✓
SDPyrexia · · ✓
SDRhinorrhoea · · ✓
SDVomiting · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…